BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18368125)

  • 21. HIV-1-Tat potentiates CXCL12/stromal cell-derived factor 1-induced downregulation of membrane CXCR4 in T lymphocytes through protein kinase C zeta.
    Hidalgo-Estévez AM; Punzón C; Sanchez-Duffhues G; Muñoz E; Fresno M
    Mol Immunol; 2008 Nov; 46(1):106-15. PubMed ID: 18760839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Divalent Cations in HIV-1 Replication and Pathogenicity.
    Khan N; Chen X; Geiger JD
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32326317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient Thresholding: A Mechanism Enabling Noncooperative Transcriptional Circuitry to Form a Switch.
    Aull KH; Tanner EJ; Thomson M; Weinberger LS
    Biophys J; 2017 Jun; 112(11):2428-2438. PubMed ID: 28591615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The two sides of Tat.
    Barboric M; Fujinaga K
    Elife; 2016 Jan; 5():e12686. PubMed ID: 26783762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    Chen S; Chen R; He M; Pang R; Tan Z; Yang M
    Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus type 1 chronic infection is associated with different gene expression in MT-4, H9 and U937 cell lines.
    Olivares I; Ballester A; Lombardia L; Dominguez O; López-Galíndez C
    Virus Res; 2009 Jan; 139(1):22-31. PubMed ID: 19000723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.
    Gatto B; Tabarrini O; Massari S; Giaretta G; Sabatini S; Del Vecchio C; Parolin C; Fravolini A; Palumbo M; Cecchetti V
    ChemMedChem; 2009 Jun; 4(6):935-8. PubMed ID: 19283692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cultured human endothelial cells expressing HIV-1 Vpu and Tat support the expansion of malignant B cells from primary central nervous system lymphoma.
    Smith JR; Henderson WW; Rosenbaum JT; Neuwelt EA; Moses AV
    Br J Ophthalmol; 2008 Feb; 92(2):297-9. PubMed ID: 18227216
    [No Abstract]   [Full Text] [Related]  

  • 29. Dilated cardiomyopathy in transgenic mice expressing HIV Tat.
    Fang Q; Kan H; Lewis W; Chen F; Sharma P; Finkel MS
    Cardiovasc Toxicol; 2009 Mar; 9(1):39-45. PubMed ID: 19337863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New nordihydroguaiaretic acid derivatives as anti-HIV agents.
    Hwu JR; Hsu MH; Huang RC
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1884-8. PubMed ID: 18321703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin.
    Asamitsu K; Yamaguchi T; Nakata K; Hibi Y; Victoriano AF; Imai K; Onozaki K; Kitade Y; Okamoto T
    J Biochem; 2008 Nov; 144(5):581-9. PubMed ID: 18713798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs.
    Nicoli F; Sforza F; Gavioli R
    AIDS; 2015 Jan; 29(1):133-4. PubMed ID: 25562499
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduced expression of Blimp-1 in memory B cells in patients with HIV-1 infection suggests distinct roles of this molecule for B and T cell regulation.
    Beisel C; Toth I; van Lunzen J; Schulze Zur Wiesch J
    AIDS; 2014 Oct; 28(16):2489-91. PubMed ID: 25265234
    [No Abstract]   [Full Text] [Related]  

  • 34. Single-Molecule Threshold of HIV Fate Decision.
    Wollman R
    Biophys J; 2017 Jun; 112(11):2247-2248. PubMed ID: 28591597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The elephant and the blind men: making sense of the seemingly multifaceted role of Blimp-1 in HIV-1 infection.
    Schulze Zur Wiesch J; Beisel C
    AIDS; 2015 Jan; 29(1):134-6. PubMed ID: 25562500
    [No Abstract]   [Full Text] [Related]  

  • 36. An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer.
    Weinberger LS; Shenk T
    PLoS Biol; 2007 Jan; 5(1):e9. PubMed ID: 17194214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Post-Transcriptional Feedback Mechanism for Noise Suppression and Fate Stabilization.
    Hansen MMK; Wen WY; Ingerman E; Razooky BS; Thompson CE; Dar RD; Chin CW; Simpson ML; Weinberger LS
    Cell; 2018 Jun; 173(7):1609-1621.e15. PubMed ID: 29754821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-Transcriptional Noise Control.
    Hansen MMK; Weinberger LS
    Bioessays; 2019 Jul; 41(7):e1900044. PubMed ID: 31222776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multisensory integration weightings underlying haptic feedback in laparoscopic surgery.
    Gildersleeve MJ
    Asian J Endosc Surg; 2012 Nov; 5(4):207. PubMed ID: 23095303
    [No Abstract]   [Full Text] [Related]  

  • 40. Heritable change caused by transient transcription errors.
    Gordon AJ; Satory D; Halliday JA; Herman C
    PLoS Genet; 2013 Jun; 9(6):e1003595. PubMed ID: 23825966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.